Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to

Zephyr, Jacqueto; Rao, Desaboini Nageswara; Vo, Sang V.; Henes, Mina; Kosovrasti, Klajdi; Matthew, Ashley N.; Hedger, Adam K.; Timm, Jennifer; Chan, Elise T.; Ali, Akbar; Yilmaz, Nese Kurt; Schiffer, Celia A.

doi:10.1016/j.jmb.2022.167503

Title: Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to

Journal Article · 01 May 2022 · J. Mol. Biol.

DOI:https://doi.org/10.1016/j.jmb.2022.167503· OSTI ID:1863036

Zephyr, Jacqueto; Rao, Desaboini Nageswara; Vo, Sang V.; Henes, Mina; Kosovrasti, Klajdi; Matthew, Ashley N.; Hedger, Adam K.; Timm, Jennifer; Chan, Elise T.; Ali, Akbar; Yilmaz, Nese Kurt; Schiffer, Celia A.

Cite

Export

Save

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; NIGMS; National Institutes of Health (NIH)

OSTI ID:: 1863036

Journal Information:: J. Mol. Biol., Vol. 434, Issue (9)

Country of Publication:: United States

Language:: ENGLISH

References (46)

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study Blach, Sarah; Zeuzem, Stefan; Manns, Michael The Lancet Gastroenterology & Hepatology, Vol. 2, Issue 3 https://doi.org/10.1016/S2468-1253(16)30181-9	journal	March 2017
Chronic hepatitis C and liver fibrosis Sebastiani, Giada World Journal of Gastroenterology, Vol. 20, Issue 32 https://doi.org/10.3748/wjg.v20.i32.11033	journal	January 2014
The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control Bukh, Jens Journal of Hepatology, Vol. 65, Issue 1 https://doi.org/10.1016/j.jhep.2016.07.035	journal	October 2016
Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants Jensen, Sanne Brun; Fahnøe, Ulrik; Pham, Long V. Hepatology, Vol. 70, Issue 3 https://doi.org/10.1002/hep.30647	journal	June 2019
Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172 Soumana, Djadé I.; Kurt Yilmaz, Nese; Prachanronarong, Kristina L. ACS Chemical Biology, Vol. 11, Issue 4 https://doi.org/10.1021/acschembio.5b00647	journal	January 2016
Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir Timm, Jennifer; Kosovrasti, Klajdi; Henes, Mina ACS Chemical Biology, Vol. 15, Issue 2 https://doi.org/10.1021/acschembio.9b00675	journal	December 2019
Evaluating the Role of Macrocycles in the Susceptibility of Hepatitis C Virus NS3/4A Protease Inhibitors to Drug Resistance Ali, Akbar; Aydin, Cihan; Gildemeister, Reinhold ACS Chemical Biology, Vol. 8, Issue 7 https://doi.org/10.1021/cb400100g	journal	May 2013
Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi® Taylor, James G.; Zipfel, Sheila; Ramey, Kyla Bioorganic & Medicinal Chemistry Letters, Vol. 29, Issue 16 https://doi.org/10.1016/j.bmcl.2019.03.037	journal	August 2019
Fluorine in Medicinal Chemistry Böhm, Hans-Joachim; Banner, David; Bendels, Stefanie ChemBioChem, Vol. 5, Issue 5 https://doi.org/10.1002/cbic.200301023	journal	April 2004
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design Meanwell, Nicholas A. Journal of Medicinal Chemistry, Vol. 61, Issue 14 https://doi.org/10.1021/acs.jmedchem.7b01788	journal	February 2018
Fluorine‐Containing Drugs Approved by the FDA in 2018 Mei, Haibo; Han, Jianlin; Fustero, Santos Chemistry – A European Journal, Vol. 25, Issue 51 https://doi.org/10.1002/chem.201901840	journal	July 2019
Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel Kang, Dongwei; Ruiz, F. Xavier; Feng, Da Journal of Medicinal Chemistry, Vol. 63, Issue 3 https://doi.org/10.1021/acs.jmedchem.9b01769	journal	January 2020
Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ Ojima, Iwao; Awasthi, Divya; Wei, Longfei Journal of Fluorine Chemistry, Vol. 196 https://doi.org/10.1016/j.jfluchem.2016.07.020	journal	April 2017
Syntheses and structure–activity relationships of novel 3′-difluoromethyl and 3′-trifluoromethyl-taxoids Kuznetsova, Larissa V.; Pepe, Antonella; Ungureanu, Ioana M. Journal of Fluorine Chemistry, Vol. 129, Issue 9 https://doi.org/10.1016/j.jfluchem.2008.05.013	journal	September 2008
Synthesis, broad spectrum antibacterial activity, and X-ray co-crystal structure of the decoding bacterial ribosomal A-site with 4′-deoxy-4′-fluoro neomycin analogs Hanessian, S.; Saavedra, O. M.; Vilchis-Reyes, M. A. Chem. Sci., Vol. 5, Issue 12 https://doi.org/10.1039/C4SC01626B	journal	January 2014
Toxicity Modulation, Resistance Enzyme Evasion, and A-Site X-ray Structure of Broad-Spectrum Antibacterial Neomycin Analogs Maianti, Juan Pablo; Kanazawa, Hiroki; Dozzo, Paola ACS Chemical Biology, Vol. 9, Issue 9 https://doi.org/10.1021/cb5003416	journal	July 2014
Harnessing Fluorine–Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs Bauer, Matthias R.; Jones, Rhiannon N.; Baud, Matthias G. J. ACS Chemical Biology, Vol. 11, Issue 8 https://doi.org/10.1021/acschembio.6b00315	journal	June 2016
Understanding organofluorine chemistry. An introduction to the C–F bond O'Hagan, David Chem. Soc. Rev., Vol. 37, Issue 2 https://doi.org/10.1039/B711844A	journal	January 2008
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing Sun, Li-Qiang; Mull, Eric; Zheng, Barbara Journal of Medicinal Chemistry, Vol. 59, Issue 17 https://doi.org/10.1021/acs.jmedchem.6b00821	journal	August 2016
Toward the Synthesis of Fluorinated Analogues of HCV NS3/4A Serine Protease Inhibitors Using Methyl α-Amino-β-fluoro-β-vinylcyclopropanecarboxylate as Key Intermediate Milanole, Gaëlle; Andriessen, Floris; Lemonnier, Gérald Organic Letters, Vol. 17, Issue 12 https://doi.org/10.1021/acs.orglett.5b01216	journal	June 2015
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection Sun, Li-Qiang; Mull, Eric; D’Andrea, Stanley Journal of Medicinal Chemistry, Vol. 63, Issue 23 https://doi.org/10.1021/acs.jmedchem.0c01296	journal	November 2020
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding Romano, K. P.; Ali, A.; Royer, W. E. Proceedings of the National Academy of Sciences, Vol. 107, Issue 49 https://doi.org/10.1073/pnas.1006370107	journal	November 2010
Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants Matthew, Ashley N.; Zephyr, Jacqueto; Hill, Caitlin. J. Journal of Medicinal Chemistry, Vol. 60, Issue 13 https://doi.org/10.1021/acs.jmedchem.7b00426	journal	June 2017
Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors Matthew, Ashley N.; Zephyr, Jacqueto; Nageswara Rao, Desaboini mBio, Vol. 11, Issue 2 https://doi.org/10.1128/mBio.00172-20	journal	April 2020
Discovery of Quinoxaline-Based P1–P3 Macrocyclic NS3/4A Protease Inhibitors with Potent Activity against Drug-Resistant Hepatitis C Virus Variants Nageswara Rao, Desaboini; Zephyr, Jacqueto; Henes, Mina Journal of Medicinal Chemistry, Vol. 64, Issue 16 https://doi.org/10.1021/acs.jmedchem.1c00554	journal	August 2021
A Weak Attractive Interaction between Organic Fluorine and an Amide Group Hof, Fraser; Scofield, Denise M.; Schweizer, W. Bernd Angewandte Chemie International Edition, Vol. 43, Issue 38 https://doi.org/10.1002/anie.200460781	journal	September 2004
Orthogonal Multipolar Interactions in Structural Chemistry and Biology Paulini, Ralph; Müller, Klaus; Diederich, François Angewandte Chemie International Edition, Vol. 44, Issue 12 https://doi.org/10.1002/anie.200462213	journal	February 2005
The observation of a large gauche preference when 2-fluoroethylamine and 2-fluoroethanol become protonated Briggs, Caroline R. S.; Allen, Mark J.; O'Hagan, David Organic & Biomolecular Chemistry, Vol. 2, Issue 5 https://doi.org/10.1039/b312188g	journal	January 2004
Intimate Interactions with Carbonyl Groups: Dipole–Dipole or n →π*? Kamer, Kimberli J.; Choudhary, Amit; Raines, Ronald T. The Journal of Organic Chemistry, Vol. 78, Issue 5 https://doi.org/10.1021/jo302265k	journal	December 2012
Hydrogen Bonding Interactions of Covalently Bonded Fluorine Atoms: From Crystallographic Data to a New Angular Function in the GRID Force Field Carosati, Emanuele; Sciabola, Simone; Cruciani, Gabriele Journal of Medicinal Chemistry, Vol. 47, Issue 21 https://doi.org/10.1021/jm0498349	journal	September 2004
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors Romano, Keith P.; Ali, Akbar; Aydin, Cihan PLoS Pathogens, Vol. 8, Issue 7 https://doi.org/10.1371/journal.ppat.1002832	journal	July 2012
Structural Analysis of Asunaprevir Resistance in HCV NS3/4A Protease Soumana, Djadé I.; Ali, Akbar; Schiffer, Celia A. ACS Chemical Biology, Vol. 9, Issue 11 https://doi.org/10.1021/cb5006118	journal	September 2014
Van der Waals Radii of Elements Batsanov, S. S. Inorganic Materials, Vol. 37, Issue 9, p. 871-885 https://doi.org/10.1023/A:1011625728803	journal	September 2001
Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein–Ligand Complexes Pollock, Jonathan; Borkin, Dmitry; Lund, George Journal of Medicinal Chemistry, Vol. 58, Issue 18 https://doi.org/10.1021/acs.jmedchem.5b00975	journal	September 2015
Fluorine in Pharmaceuticals: Looking Beyond Intuition Muller, K.; Faeh, C.; Diederich, F. Science, Vol. 317, Issue 5846 https://doi.org/10.1126/science.1131943	journal	September 2007
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials Krishnan, Preethi; Pilot-Matias, Tami; Schnell, Gretja Antimicrobial Agents and Chemotherapy, Vol. 62, Issue 10 https://doi.org/10.1128/AAC.01249-18	journal	October 2018
In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir Ng, Teresa I.; Tripathi, Rakesh; Reisch, Thomas Antimicrobial Agents and Chemotherapy, Vol. 62, Issue 1 https://doi.org/10.1128/AAC.01620-17	journal	January 2018
Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C Heo, Young-A; Deeks, Emma D. Drugs, Vol. 78, Issue 5 https://doi.org/10.1007/s40265-018-0895-5	journal	March 2018
Use of a Fluorescence Plate Reader for Measuring Kinetic Parameters with Inner Filter Effect Correction Liu, Yaya; Kati, Warren; Chen, Chih-Ming Analytical Biochemistry, Vol. 267, Issue 2 https://doi.org/10.1006/abio.1998.3014	journal	February 1999
[20] Processing of X-ray diffraction data collected in oscillation mode Otwinowski, Zbyszek; Minor, Wladek Macromolecular Crystallography Part A, 307-326 https://doi.org/10.1016/S0076-6879(97)76066-X	book	January 1997
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids Davis, I. W.; Leaver-Fay, A.; Chen, V. B. Nucleic Acids Research, Vol. 35, Issue Web Server https://doi.org/10.1093/nar/gkm216	journal	May 2007
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures Brünger, Axel T. Nature, Vol. 355, Issue 6359 https://doi.org/10.1038/355472a0	journal	January 1992
Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed To Be Robust against Drug Resistance Nalam, Madhavi N. L.; Ali, Akbar; Altman, Michael D. Journal of Virology, Vol. 84, Issue 10 https://doi.org/10.1128/JVI.02531-09	journal	March 2010

Similar Records

Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to Avoid Drug Resistance

Journal Article · 2022 · Journal of Molecular Biology · OSTI ID:1863036

Zephyr, Jacqueto; Nageswara Rao, Desaboini; Vo, Sang V.; +9 more

Molecular and Structural Mechanism of Pan-Genotypic HCV NS3/4A Protease Inhibition by Glecaprevir

Journal Article · 2020 · ACS Chem. Biol. · OSTI ID:1863036

Timm, Jennifer; Kosovrasti, Klajdi; Henes, Mina; +5 more

Depeptidization efforts on P[subscript 3]-P[prime subscript 2] [alpha]-ketoamide inhibitors of HCV NS3-4A serine protease: Effect on HCV replicon activity

Journal Article · 2013 · Bioorg. Med. Chem. Lett. · OSTI ID:1863036

Bogen, Stephane L.; Ruan, Sumei; Liu, Rong; +7 more

Title: Deciphering the Molecular Mechanism of HCV Protease Inhibitor Fluorination as a General Approach to

Citation Formats

References (46)

Similar Records

Related Subjects